Design, synthesis and evaluation of trofinetide prodrug based on diketopiperazine strategy
{{output}}
Trofinetide is the only drug approved worldwide for the treatment of Rett syndrome, a rare pediatric disease. However, its extremely short half-life, large oral dose, high incidence of gastrointestinal adverse reactions, and consequently high treatment costs p... ...
